Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A

Journal of Virology

Volumn 86, Issue 18, 2012, Pages 10221-10225

  Chowdhury, Joydip Bhanja ^a   Shrivastava, Shubham ^a   Steele, Robert ^a   Di Bisceglie, Adrian M ^a,b   Ray, Ranjit ^a,b   Ray, Ratna B ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Saint Louis University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 130A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERFERON INDUCED TRANSMEMBRANE 1 GENE; LIVER CELL CULTURE; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPLICON; RNA REPLICATION; STABLE EXPRESSION; UPREGULATION; VIRUS GENE; VIRUS REPLICATION; VIRUS VIRULENCE;

ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; CELL LINE; GENE KNOCKDOWN TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HOST-PARASITE INTERACTIONS; HUMANS; MICRORNAS; RNA, VIRAL; UP-REGULATION; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 84866144505     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00882-12     Document Type: Article

References (21)

1. Ambros V. 2004. The functions of animal microRNAs. Nature 431:350-355.
2. Ambros V, Lee RC, Lavanway A, Williams PT, Jewell D. 2003. Micro-RNAs and other tiny endogenous RNAs in C. elegans. Curr. Biol. 13:807-818.
3. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
4. Bihrer V, et al. 2011. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 106:1663-1669.
5. Brass AL, et al. 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254.
6. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. 2011. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 6:e23937. doi:10.1371/journal.pone.0023937.
7. Choo QL, et al. 1989. Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome. Science 244:359-362.
8. Farazi TA, Spitzer JI, Morozov P, Tuschl T. 2011. miRNAs in human cancer. J. Pathol. 223:102-115.
9. Filipowicz W, Bhattacharyya SN, Sonenberg N. 2008. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9:102-114.
10. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR. 1984. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38:745-755.
11. Jiang D, et al. 2010. Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J. Virol. 84:8332-8341.
12. Kanda T, et al. 2006. Generation of infectious hepatitis C virus in immortalized human hepatocytes. J. Virol. 80:4633-4639.
13. Kuiken C, Simmonds P. 2009. Nomenclature and numbering of the hepatitis C virus. Methods Mol. Biol. 510:33-53.
14. Lu J, et al. 2011. The IFITM proteins inhibit HIV-1 infection. J. Virol. 85:2126-2137.
15. Peng X, et al. 2009. Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers. BMC Genomics 10:373.
16. Raychoudhuri A, et al. 2011. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J. Virol. 85:12881-12889.
17. Ru P, Steele R, Hsueh EC, Ray RB. 2011. Anti-miR-203 upregulates SOCS3 expression in breast cancer cells and enhances cisplatin chemosensitivity. Genes Cancer 2:720-727.
18. Steele R, Mott JL, Ray RB. 2010. MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells. Genes Cancer 1:381-387.
19. Tavis JE, Donlin MJ, Aurora R, Fan X, Di Bisceglie AM. 2011. Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics. Genome Med. 3:8.
20. Varnholt H, et al. 2008. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47:1223-1232.
21. Yang JD, Roberts LR. 2010. Hepatocellular carcinoma: a global view. Nat. Rev. Gastroenterol. Hepatol. 7:448-458.